Quarterly report pursuant to Section 13 or 15(d)

Revision to Prior Period Financial Statements (Tables)

v3.21.1
Revision to Prior Period Financial Statements (Tables)
3 Months Ended
Mar. 31, 2021
Revision To Prior Period Financial Statements [Abstract]  
Restatement Of Balance Sheet
    
As of March 18, 2021
 
    
As Previously

Reported
    
Restatement
Adjustment
    
As Restated
 
Balance Sheet
                          
Total assets
   $ 981,444,800      $ —        $ 981,444,800  
    
 
 
    
 
 
    
 
 
 
Liabilities and stockholders’ equity
                          
Total current liabilities
   $ 2,015,571      $ —        $ 2,015,571  
Deferred legal fees
     18,183        —          18,183  
Deferred underwriting commissions
     34,212,500                 34,212,500  
Derivative warrant liabilities
     —          35,160,700        35,160,700  
    
 
 
    
 
 
    
 
 
 
Total liabilities
     36,246,254        35,160,700        71,406,954  
Class A common stock, $0.0001 par value; shares subject to possible redemption
     940,198,540        (35,160,700      905,037,840  
Stockholders’ equity
                          
Preferred stock- $0.0001 par value
     —          —          —    
Class A common stock—$0.0001 par value
     373        352        725  
Class B common stock—$0.0001 par value
     2,444        —          2,444  
Additional
paid-in-capital
     5,087,286        1,111,128        6,198,414  
Accumulated deficit
     (90,097      (1,111,480      (1,201,577
    
 
 
    
 
 
    
 
 
 
Total stockholders’ equity
     5,000,006        —          5,000,006  
    
 
 
    
 
 
    
 
 
 
Total liabilities and stockholders’ equity
   $ 981,444,800      $ —        $ 981,444,800